Skip to content

Exercise as Cardio Protective Modulates in Diabetic Patients

Supervised Aerobic Exercise as Anti-adiposity and Cardioprotective Modulates in Patients With Type 2 Diabetes Mellitus

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03925519
Enrollment
50
Registered
2019-04-24
Start date
2013-01-25
Completion date
2014-05-26
Last updated
2019-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Exercise

Brief summary

* Physical exercise for 6 months produced significant improvement in adiponectin, hs-CRP, and nitric oxide (NO) and was significantly correlated with adiposity markers, lipid profile and glycemic control factors in both obese and non-obese diabetic patients. * Patients with good physical activity reported a significant decrease in BMI, CHD risk scores, reduced hs-CRP, an increase in the levels of adiponectin and nitric oxide. * In patients with type 2 diabetes mellitus, adiposity markers, lipid profile, hs-CRP, and adiponectin were significantly improved following moderate exercise interventions

Detailed description

To elucidate the potential role of exercise as anti-adiposity and anti-cardio protective modulates, we thought to investigate the effect of supervised aerobic training of moderate intensity on adiposity markers, nitric oxide level, plasma adiponectin, hs-CRP, and its association with CHD risk score in obese and non-obese patients with type 2 diabetes.

Interventions

Sponsors

King Saud University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* patients with type 2 diabetes for more than 5 years. * Patients who were diagnosed according to the criteria of the American diabetes association. * Not receiving any drugs affecting the data obtained * had Normal daily diets * Not participating in any other exercise programs * Without any musculoskeletal disorders affecting an exercise program

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Estimation of coronary heart disease risk scoresix monthsThe incidence risk score of coronary heart disease among type 2 diabetic participants .patients were classified into T2DM patients with high CHD risk (UKPDS risk ; ≥ 20%), moderate CHD risk (UKPDS risk ; 10-20%), and low (UKPDS risk;\< 10%) .
Analysis of blood sugar, glycated hemoglobin (HbA1c)six monthsBlood glucose was measured using a glucose oxidase and peroxidase (GOD-POD) colorimetric method before and after exercise training

Secondary

MeasureTime frameDescription
Analysis of Nitric Oxidesix monthsPlasma NO concentration was estimated as nitrate and nitrite using High Performance Liquid Chromatography technology (HPLC). Patients were subjected for nitri oxide analysis before and after exercise training interventions

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026